Epoetin price?

Current Market Price of Epoetin

Epoetin, also known as recombinant human erythropoietin (rHuEPO), is a medication used to stimulate the production of red blood cells in patients with anemia associated with chronic kidney disease, HIV infection, or cancer chemotherapy [1].

Retail Prices in the United States

The retail prices of Epoetin in the United States can vary depending on the specific formulation, dosage, and brand. According to DrugPatentWatch.com, Epoetin is marketed under the brand names Epogen and Procrit, which are manufactured by Johnson & Johnson and Amgen, respectively.

As of my knowledge cutoff in [2023], the retail prices for a single vial of Epoetin in the United States are as follows:

* Epogen (40,000 units/mL, 1 mL vial): $1,300 - $1,500 [2]
* Epogen (10,000 units/mL, 1 mL vial): $325 - $375 [2]
* Procrit (20,000 units/mL, 1 mL vial): $1,100 - $1,300 [3]

Please note that these prices are subject to change over time and may not reflect the current market prices.

Generic and Biosimilar Alternatives

Generic and biosimilar versions of Epoetin are available in some countries, which can offer a lower price point compared to the branded versions. However, the availability and price of these alternatives can vary depending on the country and local regulations.

Regulatory and Patent Considerations

The exclusive marketing rights for Epoetin are held by Johnson & Johnson and Amgen. The patents for Epoetin are set to expire in [2028], which may lead to an increase in generic and biosimilar competition in the market.

Sources:

[1] https://www.drugs.com/epoetin-alfa.html
[2] https://www.drugpatentwatch.com/dpwa/epogen.html
[3] https://www.drugpatentwatch.com/dpwa/procrit.html